RPTX
Closed
Repare Therapeutics Inc
1.42
+0.03 (+2.16%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 1.39
Day's Range: 1.38 - 1.45
Send
sign up or login to leave a comment!
When Written:
8.63
Repare Therapeutics Inc. is a clinical-stage precision oncology company that focuses on developing novel therapies for genetically defined cancers. The company is headquartered in Montreal, Canada, and was founded in 2016.
Repare Therapeutics' approach is based on synthetic lethality, a concept where the combination of two genetic mutations results in cell death. The company utilizes its proprietary SNIPRx platform to identify synthetic lethality targets and develop small molecule drugs that selectively kill cancer cells.
Repare Therapeutics has a pipeline of programs targeting various cancer types, including breast, ovarian, prostate, and lung cancers. Its lead program, RP-3500, is in Phase 1 clinical trials for the treatment of solid tumors.
The company has partnerships with Bristol Myers Squibb and Vertex Pharmaceuticals to develop therapies for genetically defined cancers. Repare Therapeutics went public in June 2020 and is listed on the Nasdaq under the ticker symbol RPTX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Repare Therapeutics' approach is based on synthetic lethality, a concept where the combination of two genetic mutations results in cell death. The company utilizes its proprietary SNIPRx platform to identify synthetic lethality targets and develop small molecule drugs that selectively kill cancer cells.
Repare Therapeutics has a pipeline of programs targeting various cancer types, including breast, ovarian, prostate, and lung cancers. Its lead program, RP-3500, is in Phase 1 clinical trials for the treatment of solid tumors.
The company has partnerships with Bristol Myers Squibb and Vertex Pharmaceuticals to develop therapies for genetically defined cancers. Repare Therapeutics went public in June 2020 and is listed on the Nasdaq under the ticker symbol RPTX.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!